185
Participants
Start Date
April 30, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
coenzyme Q10
antioxidant and mitochondrial cofactor, given in capsules three times daily
Placebo
Placebo capsules, indistinguishable from CoQ10 capsules, given three times daily
Columbia Presbyterian Medical Center, The Neurological Institute, New York
State University of New York Upstate Medical, Neurology Department, Syracuse
Drexel University, Dept of Neurology, Philadelphia
University of Kentucky, Dept of Neurology, College of Medicine, Lexington
Cleveland Clinic Foundation, Cleveland
Minneapolis Medical Research Foundation, ,, Minneapolis
Northwestern University, Department of Neurology,, Chicago
University of Chicago, Department of Neurology, Chicago
Washington University in St. Louis School of Medicine, Department of Neurology, St Louis
University of Kansas Medical Center, Kansas City
University of Arkansas for Medical Sciences, Department of Neurology, Little Rock
University of Texas, Health Science Center at San Antonio, Division of Neurology, San Antonio
University of Colorado Health Sciences, Dept of Neurology, Denver
California Pacific Medical Center, San Francisco
University of California at San Francisco, San Francisco
Yale University School of Medicine, Department of Neurology, New Haven
Brigham and Women's Hospital , Department of Neurology, Boston
Baystate Medical Center, Division of Critical Care Research, Springfield
University of Vermont, Neurology Department, Burlington
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Columbia University
OTHER